China NMPA Product Recall - Argon-enhanced electrosurgical system, electrosurgical instruments

Medtronic (Shanghai) Management Co., Ltd., on behalf of its subsidiary Covidien Medical Devices International Trading (Shanghai) Co., Ltd., initiated a voluntary Level II recall of specific Argon-Enhanced Electrosurgical Systems and Electrosurgical Instruments. This recall, formally documented by the National Medical Products Administration (NMPA) on September 29, 2016, followed the company's report on July 29, 2016.

The core issue identified was a sealing defect in the inner packaging of several Covidien Valleylab™ laparoscopic electrodes. This defect carries the risk of compromising the sterile barrier of the products, thereby increasing the potential for patient infection during surgical procedures. Although no serious injuries related to this specific issue had been reported at the time, the recall was deemed necessary to ensure patient safety. The affected products are globally distributed, with 103 boxes sold in China, and are utilized in both open and laparoscopic surgeries for electrosurgical cutting and coagulation.

As a corrective action, all customers possessing the affected products are required to inspect their inventory for the specified models and batch numbers of Covidien Valleylab™ laparoscopic electrodes. Upon identification, these items must be returned to Medtronic following the instructions provided in customer communications.